Ahrens Brenton Karl

DirectorIterum Therapeutics plc (ITRM) · full profile →Form 4 · filed Sep 20, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$68K
Net Open-Market Flow
-$68K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 20, 2022Sell(S)7K$1.78$13K0
Sep 19, 2022Sell(S)15K$1.77$27K7K
Sep 16, 2022Sell(S)15K$1.90$29K22K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-031603) within minutes of acceptance. Every field above traces to the original document. Verify it directly: